Ligand-mediated Release
Ligand-Mediated Release is a controlled release mechanism in which the targeted and selective delivery of a therapeutic agent is achieved through the specific binding interaction between a ligand conjugated to the drug carrier and its corresponding receptor on the target cell or tissue.
127
Publications
10.7K
Citations
707
Authors
273
Institutions
Publications per year
2017–2026
31
127
Metalloproteinase-mediated release of human Fas ligand.
Nobuhiko Kayagaki, Tomohiko Ebata, Hiroshi Ohmoto et al. · The Journal of Experimental Medicine · 1995 · 831 citations · Full text
Life Sciences, Immunology, Pathology +15
Ofer Levy, Kol A. Zarember, René M. Roy et al. · The Journal of Immunology · 2004 · 377 citations · Full text
Keisuke Horiuchi, Sylvain Le Gall, Marc Schulte et al. · Molecular Biology of the Cell · 2006 · 309 citations · Full text
1–5 of 127
707
4
h-index
3
h-index
Massachusetts Institute of Technology, United States
3 publications · 378 citations
3
h-index
3
h-index
3
h-index
1–5 of 707
273
Harvard University
Cambridge, United States
7 h-index
19 publications
2.2K citations
Center for Cancer Research
Bethesda, United States
5 h-index
30 publications
3.7K citations
University of Oxford
Oxford, United Kingdom
3 h-index
9 publications
816 citations

Centre National de la Recherche Scientifique
Paris, France
3 h-index
18 publications
1.3K citations

University of Huddersfield
Huddersfield, United Kingdom
3 h-index
12 publications
318 citations
KU Leuven
Leuven, Belgium
3 h-index
7 publications
606 citations

The University of Sydney
Sydney, Australia
3 h-index
7 publications
365 citations
National Institutes of Health
Bethesda, United States
3 h-index
15 publications
1.8K citations
1–8 of 273
JBC · 8 publications · 821 citations
8
h-index
8 publications · 236 citations
8
h-index
5 publications · 136 citations
5
h-index
5 publications · 235 citations
5
h-index
4 publications · 180 citations
4
h-index
1–5